A BRD4 PROTAC nanodrug for glioma therapy via the intervention of tumor cells proliferation, apoptosis and M2 macrophages polarization
Glioma is a primary aggressive brain tumor with high recurrence rate. The poor efficiency of chemotherapeutic drugs crossing the blood‒brain barrier (BBB) is well-known as one of the main challenges for anti-glioma therapy. Moreover, massive infiltrated tumor-associated macrophages (TAMs) in glioma...
Saved in:
Main Authors: | Tingting Yang (Author), Yuzhu Hu (Author), Junming Miao (Author), Jing Chen (Author), Jiagang Liu (Author), Yongzhong Cheng (Author), Xiang Gao (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel gene therapy for drug-resistant melanoma: Synergistic combination of PTEN plasmid and BRD4 PROTAC-loaded lipid nanocarriers
by: Aishwarya Saraswat, et al.
Published: (2024) -
An instructive attempt on developing aptamer-constructed PROTAC for breast cancer treatment
by: Yuzhu Zhang, et al.
Published: (2022) -
Nanodrugs Detonate Lysosome Bombs
by: Yuting Xiang, et al.
Published: (2022) -
The effect of Jian Gan powder on the proliferation, migration and polarization of macrophages and relative mechanism
by: Kun Li, et al.
Published: (2024) -
Mir-29c Expression in Glioma and Its Effects on Tumor Cell Proliferation and Apoptosis
by: Peiquan HUI, et al.
Published: (2020)